Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Noncanonical Cell Fate Regulation by Bcl-2 Proteins — Stephen Jun Fei Chong (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Noncanonical Cell Fate Regulation by Bcl-2 Proteins
Shared by
Guido Guido Kroemer
Noncanonical Cell Fate Regulation by Bcl-2 Proteins
Article
2020
en
Authors
+3 more
SC
Stephen Jun Fei Chong
SM
Saverio Marchi
GP
Giulia Petroni
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins
Isabel Marzo
,
Catherine Brenner
,
Naoufal Zamzami
,
Santos A. Susín
,
Gisela Beutner
,
Dieter Brdiczka
,
René Rémy
,
Zhihua Xie
,
John C. Reed
,
Guido Guido Kroemer
Article
2014
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
Yohann Loriot
,
Pierre Mordant
,
Delphine Dugué
,
Olivier Geneste
,
Andrea Gombos
,
Paule Opolon
,
Jean‐François Guégan
,
Jean‐Luc Perfettini
,
Alain Pierré
,
L. Kraus Berthier
,
Guido Guido Kroemer
,
Jean‐Charles Soria
,
Stéphane Depil
,
Éric Deutsch
Article
2023
Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
Daniel Barriuso
,
Lucia Alvarez-Frutos
,
Lucía G. Gutiérrez
,
Omar Motiño
,
Guido Guido Kroemer
,
Roberto Palacios
,
Laura Senovilla
Article
2002
Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL
Helena L.A. Vieira
,
Patricia Boya
,
Isabelle Cohen
,
Chahrazed El Hamel
,
D. Haouzi
,
Sabine Druillenec
,
Anne-Sophie Belzacq
,
Catherine Brenner
,
Bernárd P. Roques
,
Guido Guido Kroemer
Letter
2007
BH3-Only Proteins and BH3 Mimetics Induce Autophagy by Competitively Disrupting the Interaction between Beclin 1 and Bcl-2/Bcl-X<sub>L</sub>
Maria Chiara Maiuri
,
Alfredo Criollo
,
Ezgi Tasdemir
,
José M. Vicencio
,
Nicolas Tajeddine
,
John A. Hickman
,
Olivier Geneste
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.